Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06926205 |
| Consolidated Lead Sponsor | GELLC (Grupo Español de Leucemia Linfocítica Crónica) |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 34 participants (ESTIMATED) |
| Registered Start Date | 2024-05-15 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Hospital Universitario 12 de Octubre | Madrid, Spain | Open Hospital Dossier -> |
| Hospital Universitario Central de Asturias | Oviedo, Spain | Open Hospital Dossier -> |
| Hospital Universitario de Salamanca | Salamanca, Spain | Open Hospital Dossier -> |
| Hospital Universitario Virgen del Rocío | Seville, Spain | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.